These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6091473)

  • 1. Combined ceftriaxone and surgical therapy for osteomyelitis in hospital and outpatient settings.
    Eron LJ; Goldenberg RI; Poretz DM
    Am J Surg; 1984 Oct; 148(4A):1-4. PubMed ID: 6091473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outpatient use of ceftriaxone: a cost-benefit analysis.
    Poretz DM; Woolard D; Eron LJ; Goldenberg RI; Rising J; Sparks S
    Am J Med; 1984 Oct; 77(4C):77-83. PubMed ID: 6093525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and bacteriologic efficacy of ceftriaxone in the United States.
    McCloskey RV
    Am J Med; 1984 Oct; 77(4C):97-103. PubMed ID: 6093528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of chronic osteomyelitis in a developing country using ceftriaxone-PMMA beads: an initial study.
    Alonge TO; Ogunlade SO; Omololu AB; Fashina AN; Oluwatosin A
    Int J Clin Pract; 2002 Apr; 56(3):181-3. PubMed ID: 12018822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ceftriaxone for once-a-day therapy of urinary tract infections.
    Childs SJ; Wells WG; Mirelman S
    Am J Med; 1984 Oct; 77(4C):73-6. PubMed ID: 6093524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ceftriaxone treatment of skin and soft tissue infections in a once daily regimen.
    Bradsher RW; Snow RM
    Am J Med; 1984 Oct; 77(4C):63-7. PubMed ID: 6093522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal laboratory test values during ceftriaxone therapy.
    Oakes M; MacDonald H; Wilson D
    Am J Med; 1984 Oct; 77(4C):89-96. PubMed ID: 6093527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of osteomyelitis.
    Armstrong EP; Rush DR
    Clin Pharm; 1983; 2(3):213-24. PubMed ID: 6349907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of complicated urinary tract infections with the long acting cephalosporin, ceftriaxone.
    Rothwell DL; Bremner DA; Taylor KM
    N Z Med J; 1983 May; 96(732):392-4. PubMed ID: 6302612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical adverse effects during ceftriaxone therapy.
    Moskovitz BL
    Am J Med; 1984 Oct; 77(4C):84-8. PubMed ID: 6093526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single daily dose treatment of severe refractory infections with ceftriaxone. Cost savings and possible parenteral outpatient treatment.
    Baumgartner JD; Glauser MP
    Arch Intern Med; 1983 Oct; 143(10):1868-73. PubMed ID: 6312914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ceftriaxone versus combined gentamicin and clindamycin for polymicrobial surgical sepsis.
    Stone HH; Mullins RJ; Strom PR; Bourneuf AA; Geheber CE
    Am J Surg; 1984 Oct; 148(4A):30-4. PubMed ID: 6091478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility of outpatient self-administration of parenteral antibiotics.
    Antoniskis A; Anderson BC; Van Volkinburg EJ; Jackson JM; Gilbert DN
    West J Med; 1978 Mar; 128(3):203-6. PubMed ID: 636409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous antibiotic therapy at home.
    Kind AC; Williams DN; Persons G; Gibson JA
    Arch Intern Med; 1979 Apr; 139(4):413-5. PubMed ID: 434994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variability of ceftriaxone pharmacokinetics in hospitalized patients with severe infections.
    Joos B; Luethy R; Muehlen E; Siegenthaler W
    Am J Med; 1984 Oct; 77(4C):59-62. PubMed ID: 6093521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical efficacy, tolerability, and cost savings associated with the use of open-label metronidazole plus ceftriaxone once daily compared with ticarcillin/clavulanate every 6 hours as empiric treatment for diabetic lower-extremity infections in older males.
    Clay PG; Graham MR; Lindsey CC; Lamp KC; Freeman C; Glaros A
    Am J Geriatr Pharmacother; 2004 Sep; 2(3):181-9. PubMed ID: 15561650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Once-daily ceftriaxone outpatient therapy in adults with infections.
    Tice AD
    Chemotherapy; 1991; 37 Suppl 3():7-10. PubMed ID: 1909231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ceftriaxone, a long-acting cephalosporin. Microbiological, kinetic and clinical study].
    Soranzo ML; Capra E; Angela GC; Eandi M; Salassa B; Lollini P; Musso E; Pizzo L; Spezia C; Di Nola F
    Minerva Med; 1983 Sep; 74(36):2093-102. PubMed ID: 6312379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center.
    Gauthier M; Chevalier I; Sterescu A; Bergeron S; Brunet S; Taddeo D
    Pediatrics; 2004 Oct; 114(4):e469-76. PubMed ID: 15466073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended-interval aminoglycoside dosing for treatment of enterococcal and staphylococcal osteomyelitis.
    Graham AC; Mercier RC; Achusim LE; Pai MP
    Ann Pharmacother; 2004 Jun; 38(6):936-41. PubMed ID: 15084688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.